Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 2 $ 11,757,037 $ (11,115,178) $ (2,152) $ 639,709
Balance, shares at Dec. 31, 2019 24,243        
Issuance common stock from convertible debt $ 60 585,529 585,589
Issuance common stock from convertible debt, shares 597,657        
Issuance of common stock related to exercise of options $ 9 32,991 33,000
Issuance of common stock related to exercise of options, shares 85,960        
Stock based compensation for options granted 130,400 130,400
Stock issued for services 62,750 62,750
Stock based compensation, shares 5,000        
Beneficial conversion feature of convertible debt 898,918 898,918
Comprehensive loss (19,840) (19,840)
Net loss (1,358,745) (1,358,745)
Ending balance, value at Sep. 30, 2020 $ 71 13,467,625 (12,473,923) (21,992) 971,781
Balance, shares at Sep. 30, 2020 712,860        
Beginning balance, value at Jun. 30, 2020 $ 5 11,771,789 (11,373,472) (11,018) 387,304
Balance, shares at Jun. 30, 2020 51,066        
Issuance common stock from convertible debt $ 57 570,777 570,834
Issuance common stock from convertible debt, shares 570,834        
Issuance of common stock related to exercise of options $ 9 32,991 33,000
Issuance of common stock related to exercise of options, shares 85,960        
Stock based compensation for options granted 130,400 130,400
Stock issued for services 62,750 62,750
Stock based compensation, shares 5,000        
Beneficial conversion feature of convertible debt 898,918 898,918
Comprehensive loss (10,974) (10,974)
Net loss (1,100,451) (1,100,451)
Ending balance, value at Sep. 30, 2020 $ 71 13,467,625 (12,473,923) (21,992) 971,781
Balance, shares at Sep. 30, 2020 712,860        
Beginning balance, value at Dec. 31, 2020 $ 82 14,486,492 (13,878,553) (42,832) 565,189
Balance, shares at Dec. 31, 2020 817,450        
Issuance common stock from convertible debt $ 135 1,644,132 1,644,267
Issuance common stock from convertible debt, shares 1,345,468        
Issuance of common related to offering $ 288 12,661,696 12,661,984
?Issuance of common related to offering, shares 2,880,000        
Issuance of common for over-allotment $ 43 1,983,226 1,983,269
?Issuance of common for over-allotment, shares 432,000        
Issuance of warrants for over-allotment 4,320 4,320
Issuance of common stock from exercise warrant $ 92 4,629,448 4,629,540
Issuance of common stock from exercise warrant, shares 925,908        
Issuance of common stock related to exercise of options $ 2 4,998 $ 5,000
Issuance of common stock related to exercise of options, shares 17,437       19,200
Stock based compensation for options granted 1,053,064 $ 1,053,064
Stock based compensation for restricted stock awards $ 5 268,495 268,500
Stock based compensation for restricted stock awards, shares 50,000        
Issuance of common stock for services 14,200 14,200
Issuance of common stock for services, shares 1,000        
Beneficial conversion feature of convertible debt 340,420 340,420
Comprehensive loss 42,850 42,850
Net loss (4,567,085) (4,567,085)
Ending balance, value at Sep. 30, 2021 $ 647 37,090,491 (18,445,638) 18 18,645,518
Balance, shares at Sep. 30, 2021 6,469,263        
Beginning balance, value at Jun. 30, 2021 $ 548 31,139,486 (16,140,089) (55,566) 14,944,379
Balance, shares at Jun. 30, 2021 5,476,918        
Issuance of common stock from exercise warrant $ 92 4,624,448 4,624,540
Issuance of common stock from exercise warrant, shares 924,908        
Issuance of common stock related to exercise of options $ 2 4,998 5,000
Issuance of common stock related to exercise of options, shares 17,437        
Stock based compensation for options granted 1,053,064 1,053,064
Stock based compensation for restricted stock awards $ 5 268,495 268,500
Stock based compensation for restricted stock awards, shares 50,000        
Comprehensive loss 55,584 55,584
Net loss (2,305,549) (2,305,549)
Ending balance, value at Sep. 30, 2021 $ 647 $ 37,090,491 $ (18,445,638) $ 18 $ 18,645,518
Balance, shares at Sep. 30, 2021 6,469,263